Ultrasmall superparamagnetic iron oxide enhanced MR imaging for lymph node metastases

Radiography

Volumn 13, Issue SUPPLL. 1, 2007, Pages

  Russell, Mai ^a   Anzai, Yoshimi ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Ferumoxtran; Iron oxide; Lymph nodes; Magnetic resonance imaging; Ultrasmall superparamagnetic particles

Indexed keywords

CONTRAST MEDIUM; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK CANCER; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHAGOCYTOSIS; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 37349123882     PISSN: 10788174     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radi.2007.04.001     Document Type: Article

References (42)

1. Bataskis J.G. Squamous cell carcinoma of the oral cavity and the oropharynx. In: Batsakis J.G. (Ed). Tumors of the head and neck: clinical and pathological considerations. 2nd ed. (1979), Williams & Wilkins, Baltimore 240-250
2. Pieterman R.M., van Putten J.W., Meuzelaar J.J., et al. Preoperative staging of nonsmall-cell lung cancer with positron-emission tomography. N Engl J Med 343 (2000) 254-261
3. Witte C.L., Williams W.H., and Witte J.H. Lymphatic imaging (editorial). Lymphology 26 (1993) 109-111
4. Anzai Y., Brunberg J.A., and Lufkin R.B. Imaging of nodal metastases in the head and neck. J Magn Reson Imaging 7 (1997) 774-783
5. Davis G.L. Sensitivity of frozen section examination of pelvic lymph-node for metastatic prostate carcinoma. Cancer 76 (1995) 661-666
6. Stark D.D., Weissleder R., Elizondo G., et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 168 (1988) 297-301
7. Anzai Y., Piccoli C.W., Outwater E.K., Stanford W., Bluemke D.A., Nurenberg P., et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 228 (2003) 777-788
8. Bellin M.F., and Lebleu L. Meric JB Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography. Abdom Imaging 28 (2003) 155-163
9. Weissleder R., Elizondo G., Wittenberg J., Lee A.S., Josephson L., and Brady T.J. Ultra small super paramagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175 (1990) 494-498
10. Weissleder R., Elizondo G., Wittenberg J., Lee A.S., Josephson L., and Brady T.J. Ultra small super paramagnetic iron oxide: characterization of a new class of contrast agent for MR imaging. Radiology 175 (1990) 489-493
11. Hudgins P.A., Anzai Y., Morris M.R., and Lucas M.A. Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose study. AJNR Am J Neuroradiol 23 4 (2002) 649-656
12. Sigal R., Vogl T., Casselman J., Moulin G., Veillon F., Hermans R., et al. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR)-results of a phase-III multicenter clinical trial. Eur Radiol 12 (2002) 1104-1113
13. Harishinghani M.G., Saksena M.A., Hahn P.F., King B., Kim J., Torabi M.T., et al. Ferumoxtraon-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?. Am J Roentgenol 186 (2006) 144-148
14. Harisinghani M.G., Dixon W.T., Saksena M.A., et al. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10. Radiographics 24 3 (2004 May-Jun) 867-878 [Review]
15. Anzai Y., McLachlan S., Morris M., Saxton R., and Lufkin R.B. Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck. AJNR Am J Neuroradiol 15 (1994) 87-94
16. Anzai Y., and Prince M.R. Iron oxide-enhanced MR lymphography: the evaluation of cervical lymph node, metastases in the head and neck cancer. J Magn Reson Imaging 7 (1997) 75-81
17. Lee A.S., Weissleder R., Brady T.J., and Wittenberg J. Lymph nodes: microstructural anatomy at MR imaging. Radiology 17 8 (1991) 519-522
18. Nishimura H., Taniagwa N., Hiramatsu M., Tatsumi Y., Matsuki M., and Narabayashi I. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide. J Am Col Surg 202 (2006) 604-611
19. Bellin M.F., Roy C., Kinkel K., Thoumas D., Zaim S., Vanel D., et al. Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles-initial clinical experience. Radiology 207 (1998) 799-808
20. Pannu H.K., Wang K.P., Borman T.I., and Bluemke D.A. MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent. J Magn Reson Imaging 12 (2000) 899-904
21. Koh D.M., Brown G., Temple L., Raja A., Toomey P., Bett N., et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings-initial observations. Radiology 23 (2004) 91-99
22. Curvo-Semedo L., Diniz M., Migueis J., Juliao M.J., Martins P., Pinto A., et al. USPIO-enhanced magnetic resonance imaging for nodal staging in patients with head and neck cancer. J Magn Reson Imaging 24 (2006) 123-131
23. Carr I. Lymphatic metastasis Cancer. Metastasis Rev 2 (1983) 307-317
24. Tanoura T., Bernas M., Darkazanli A., Elam E., Unger E., Witte M., et al. MR lymphography with iron oxide compound AMI-227: studies in ferrets with filariasis. AJR 159 (1992) 875-881
25. Anzai Y., Blackwell K.E., Hirschowitz S.L., Rogers J.W., Sato Y., Yuh W.T., et al. Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 192 (1994) 709-715
26. Nguyen B.C., Stanford W., Thompson B.H., Rossi N.P., Kernstine K.H., Kern J.A., et al. Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma. J Magn Reson Imaging 10 (1999) 468-473
27. Mack M.G., Balzer J.O., Straub R., Eichler K., and Vogl T.J. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology 222 (2002) 239-244
28. Michel S.C., Keller T.M., Frohlich J.M., Fink D., Caduff R., Seifert B., et al. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology 225 (2002) 527-536
29. Stets C., Brandt S., Wallis F., Buchmann J., Gilbert F.J., and Heywang-Kobrunner S.H. Axillary lymph node metastases: a statistical analysis of various parameters in MRI with USPIO. J Magn Reson Imaging 16 (2002) 60-68
30. Harisinghani M.G., Barentsz J., Hahn P.F., Deserno W.M., Tabatabaei S., van de Kaa C.H., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 (2003) 2491-2499
31. Deserno W.M., Harisinghani M.G., Taupitz M., Jager G.J., Witjes J.A., Mulders P.F., et al. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 233 (2004) 449-456
32. Keller T.M., Michel S.C., Frohlich J., Fink D., Caduff R., Marincek B., et al. USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary results. Eur Radiol 14 (2004) 937-944
33. Rockall A.G., Sohaib S.A., Harisinghani M.G., Babar S.A., Singh N., Jeyarajah A.R., et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 23 (2005) 2813-2821
34. Harishinghani M.G., Saksena M., Ross R.W., et al. A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: a new method for noninvasive lymph node evaluation. Urology 66 5 (2005 Nov) 1066-1071
35. Tatsumi Y., Tanigawa N., Nishimura H., Nomura E., Mabuchi H., Matsuki M., et al. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10. Gastric Cancer 9 (2006) 120-128
36. Stadnik T.W., Everaert H., Makkat S., Sacre R., Lamote J., and Bourgain C. Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging for axillary lymph node staing-initial findings. Eur Radiol 16 (2006) 2153-2160
37. Will O., Purkayastha S., Chan C., Athanasion T., Darzi A.W., Gedroyc W., and Tekkis P.P. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet 7 1 (2006 Jan) 52-60
38. Chang J.M., Lee H.J., Goo J.M., Lee H.Y., Lee J.J., Chung J.K., et al. False-positive and false-negative FDG-PET scans in various thoracic diseases. Korean J Radiol 7 1 (2006) 57-69
39. Lopez R., Payoux P., Gantet P., Esquerre J.P., Boutault F., and Paoli J.R. Multimodal image registration for localization of sentinel nodes in head and neck squamous cell carcinoma. J Oral Maxillofac Surg 62 12 (2004) 1497-1504
40. Hafner J., Schmid M.H., Kempf W., Burg G., Kunzi W., Meuli-Simmen C., et al. Baseline staging in cutaneous malignant melanoma. Br J Dermatol 150 4 (2004) 677-686
41. Chen S.L., Iddings D.M., Scheri R.P., and Bilchik A.J. Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin 56 5 (2006) 292-309
42. Heesakkers R.A.M., Futterer J.J., Hovels A.M., van den Bosch H.C., Scheenen T.W., Hoogeveen Y.Z., et al. Prostate cancer evaluation with ferumoxtran-10-enhanced T2*-weighted MR imaging at 1.5 and 3.0T: Early experience. Radiology 239 (2006) 481-487